What is the recommended treatment regimen for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Helicobacter pylori Infection in Westchester County, NY

Bismuth quadruple therapy for 14 days is the recommended first-line treatment for H. pylori infection in Westchester County, NY, due to high clarithromycin resistance patterns in the United States. 1, 2

First-Line Treatment Regimen

  • Bismuth quadruple therapy consists of:

    • Proton pump inhibitor (PPI) twice daily
    • Bismuth subsalicylate
    • Metronidazole
    • Tetracycline
    • Duration: 14 days 1, 2
  • This regimen is particularly effective because bacterial resistance to bismuth is extremely rare, making it effective even against strains resistant to other antibiotics 1, 2

  • High-dose PPI (twice daily) should be used to increase efficacy by reducing gastric acidity and enhancing antibiotic activity 2, 3

Alternative First-Line Options

  • In areas with low clarithromycin resistance (<15%), triple therapy may be considered:

    • PPI twice daily
    • Clarithromycin 500mg twice daily
    • Amoxicillin 1g twice daily
    • Duration: 14 days 1, 3
  • However, clarithromycin resistance is increasing globally, making traditional triple therapy less effective in many regions, including most of the United States 3

Second-Line Treatment Options

  • After failure of first-line therapy, avoid repeating antibiotics to which the patient has been previously exposed 2

  • Levofloxacin-based triple therapy is recommended as a second-line option:

    • PPI twice daily
    • Amoxicillin 1g twice daily
    • Levofloxacin
    • Duration: 10-14 days 2, 3
  • Note that FDA recommends fluoroquinolones (like levofloxacin) be used as a last choice due to risk of serious side effects 1

Third-Line and Rescue Therapies

  • After two failed eradication attempts, antibiotic susceptibility testing should guide further treatment 1, 2

  • Rifabutin-based triple therapy is an effective rescue option:

    • PPI twice daily
    • Amoxicillin 1g twice daily
    • Rifabutin
    • Duration: 14 days 1, 4
  • High-dose dual therapy with amoxicillin and PPI is another alternative for refractory cases 1

Specific FDA-Approved Regimens

  • Triple therapy (FDA-approved):

    • 1 gram amoxicillin
    • 500 mg clarithromycin
    • 30 mg lansoprazole
    • All given twice daily for 14 days 5
  • Dual therapy (FDA-approved):

    • 1 gram amoxicillin
    • 30 mg lansoprazole
    • All given three times daily for 14 days 5

Verification of Eradication

  • Confirm eradication with urea breath test or monoclonal stool antigen test:
    • At least 4 weeks after completion of therapy
    • At least 2 weeks after PPI discontinuation 1, 2

Common Pitfalls and Considerations

  • Clarithromycin resistance dramatically reduces treatment success rates from approximately 90% to 20% 3

  • Extending treatment duration to 14 days rather than 7 days improves eradication rates by approximately 5% 2, 3

  • Consider adding probiotics as adjuvant therapy to reduce side effects like diarrhea (occurs in 21-41% of patients) and improve patient compliance 1, 2

  • Patients with severe renal impairment (GFR <30 mL/min) require dose adjustments for amoxicillin 5

  • Avoid repeating antibiotics to which the patient has been previously exposed, especially clarithromycin and levofloxacin, as resistance is likely to have developed 2, 3

References

Guideline

Helicobacter Pylori Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Helicobacter pylori Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Helicobacter pylori Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.